-2%
- Tirzepatide is prescribed alongside diet and exercise to:
- Improve blood sugar control in adults with type 2 diabetes
- Aid weight management by reducing appetite and supporting weight loss when paired with a healthy lifestyle
- Type 2 Diabetes Mellitus: Used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.
- Weight Management: Indicated for chronic weight management in adults with obesity or overweight and at least one weight-related condition (e.g., hypertension, type 2 diabetes, or dyslipidemia).
- Obstructive Sleep Apnea (OSA): Used in patients with obesity-related moderate to severe OSA to support weight reduction and improve sleep-disordered breathing.
Tirzepatide is a dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It enhances glucose-dependent insulin secretion, suppresses glucagon secretion, delays gastric emptying, and promotes satiety. These actions collectively contribute to improved glycemic control and weight reduction.
